2-year persistence with different anti-osteoporosis medications: a population-based cohort by Reyes, C, Tebe, C, Martinez-Laguna, D, Soria-Castro, A, Carbonell-Abella, C, Prieto-Alhambra, D

One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. by Reyes, C, Tebe, C, Martinez-Laguna, D, Ali, M, Soria-Castro, A, Carbonell, C, Prieto-Alhambra, D

1 and 2-year persistence with different anti-osteoporosis medications per previous use and setting of therapy initiation: A population-based cohort study by Reyes, C, Tebe, C, Martinez-Laguna, D, Ali, M, Soria-Castro, A, Carbonell, C, Prieto-Alhambra, D

Use of anti-osteoporosis drugs in type 2 diabetic patients: A population-based cohort study by Martinez-Laguna, D, Carbonell-Abella, C, Soria-Castro, A, Nogues, X, Diez-Perez, A, Prieto-Alhambra, D

Validation of fragility fractures in primary care electronic medical records: a population-based study by Martinez-Laguna, D, Soria-Castro, A, Carbonell-Abella, C, Orozco, P, Estrada-Laza, P, Nogues, X, Diez-Perez, A, Prieto-Alhambra, D

El papel de la determinación de un marcador de resorción, el telopéptido carboxiterminal del colágeno I, en la valoración del cumplimiento terapéutico en pacientes tratadas con bif... by Martínez-Laguna D, Nogués X, Carbonell-Abella C, Soria Castro A, Orozco López P, Poza Martínez R, Díez-Pérez A, Prieto-Alhambra D

Get full text

Validation of fragility fractures in primary care electronic medical records: a population-based study by Martinez-Laguna, D, Soria-Castro, A, Carbonell-Abella, C, Orozco-López, P, Estrada-Laza, P, Nogues, X, Díez-Perez, D, Prieto-Alhambra, D

Riesgo de fractura asociado a los estadios previos al diagnóstico de diabetes mellitus tipo 2: Estudio de casos-controles anidados (cohorte DIAFOS) by Martínez-Laguna D, Nogués-Solán X, Díez-Pérez A, Soria-Castro A, Carbonell-Abella C, Arias-Moliz I, Estrada-Laza P, Prieto-Alhambra D

Get full text